Caleb Manscill currently serves as the Chief Technology Officer and a member of the Board of Directors at LymeDisease.org (LDo), the largest patient-influenced Lyme disease organization globally. With a robust background in startups and technology leadership, Caleb is dedicated to leveraging his expertise to enhance...
Caleb Manscill currently serves as the Chief Technology Officer and a member of the Board of Directors at LymeDisease.org (LDo), the largest patient-influenced Lyme disease organization globally. With a robust background in startups and technology leadership, Caleb is dedicated to leveraging his expertise to enhance the organization’s mission of providing reliable information and resources to those affected by Lyme disease. Under his guidance, LDo has become a trusted source, attracting over 4 million unique visitors annually to its website, where patients can access vital information and support.
One of Caleb's key projects is the innovative MyLymeData initiative, a groundbreaking big data project that empowers patients to contribute to a comprehensive database, ultimately driving research and improving treatment outcomes for Lyme disease. This initiative not only enhances patient engagement but also positions LDo at the forefront of data-driven healthcare solutions. Caleb’s strategic vision and experience in business analysis and marketing strategy have been instrumental in expanding the organization's reach and impact.
His proficiency in search engine optimization (SEO) and lead generation has also played a crucial role in increasing awareness and accessibility of Lyme disease resources. As an operator and leader with a passion for successful exits, Caleb aims to foster growth and sustainability within LDo while advocating for the Lyme disease community. His commitment to innovation and patient advocacy reflects his broader goal of creating meaningful change in the healthcare landscape, making him a pivotal figure in the fight against Lyme disease.
